Dame Anne has written to the Prime Minister to urge him to make the issue of access to breast cancer drugs a top priority, and help put breast cancer back on the agenda.
Dame Anne joined more than 70 MPs at a reception hosted by Breakthrough Breast Cancer at the House of Commons. There, the charity called on the Government to bring about a new focus on breast cancer, with a priority of introducing an equitable system through which effective new treatments are routinely made available to patients.
Earlier this year Breakthrough expressed its disappointment that two effective metastatic breast cancer drugs, everolimus (also known as Afinitor), and pertuzumab (also known as Perjeta) were rejected by NICE on the basis of cost.
Dame Anne said: “Breast cancer is not yesterday’s problem; thousands of women in the UK are living with a diagnosis of secondary breast cancer, with incredibly limited treatment options. Research is developing treatments that can give women at the end of their lives more good quality time with their loved ones; we have a responsibility to ensure that there is a system that allows these pioneering new drugs to routinely reach patients who will benefit from them.
“That’s why I’ve written to the Prime Minister to urge him to take the lead on this issue, and help improve the lives of the thousands of women who are still affected by this disease.”